First Time Loading...

Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 91.84 USD 0.05% Market Closed
Updated: Apr 30, 2024

Amedisys Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Amedisys Inc
Cash from Financing Activities Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Amedisys Inc
NASDAQ:AMED
Cash from Financing Activities
-$87.5m
CAGR 3-Years
-80%
CAGR 5-Years
20%
CAGR 10-Years
-5%
DaVita Inc
NYSE:DVA
Cash from Financing Activities
-$1.2B
CAGR 3-Years
14%
CAGR 5-Years
-13%
CAGR 10-Years
-9%
Quest Diagnostics Inc
NYSE:DGX
Cash from Financing Activities
$83m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CVS Health Corp
NYSE:CVS
Cash from Financing Activities
$2.7B
CAGR 3-Years
N/A
CAGR 5-Years
-41%
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Cash from Financing Activities
-$4.3B
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
-17%
Laboratory Corporation of America Holdings
NYSE:LH
Cash from Financing Activities
-$10.4m
CAGR 3-Years
77%
CAGR 5-Years
63%
CAGR 10-Years
26%

See Also

What is Amedisys Inc's Cash from Financing Activities?
Cash from Financing Activities
-87.5m USD

Based on the financial report for Dec 31, 2023, Amedisys Inc's Cash from Financing Activities amounts to -87.5m USD.

What is Amedisys Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-5%

Over the last year, the Cash from Financing Activities growth was -188%. The average annual Cash from Financing Activities growth rates for Amedisys Inc have been -80% over the past three years , 20% over the past five years , and -5% over the past ten years .